China Proteomics Market to Reach USD 7.99 Billion by 2032, Growing at a CAGR of 11.27% During 2026–2032

The China Proteomics Market was valued at USD 3.88 billion in 2025 and is projected to grow from USD 4.21 billion in 2026 to USD 7.99 billion by 2032, advancing at a CAGR of 11.27% during the forecast period. This growth is anchored by China's mounting cancer burden; the National Central Cancer Registry of China projects that new cancer cases among adults aged 60 and above will rise 46% between 2015 and 2030, from 2.2 million to 3.2 million, driving sustained demand for protein biomarker discovery and quantitative proteomics workflows across oncology and clinical proteomics applications.

Moreover, China's proteomics research sector is undergoing a behavioral shift toward AI-powered proteomics bioinformatics platforms, replacing manual protein analysis workflows with machine learning-driven automation. In January 2025, the Westlake Center for Intelligent Proteomics published iDIA-QC in Nature Communications, an AI model trained on 2,754 mass spectrometry files achieving an AUC of 0.97 for instrument performance detection. In April 2026, MGI Tech launched its Generative Lab Intelligence platform powered by the DeepSeek V3 large language model, enabling no-code proteomics data analysis for laboratory teams across China.

Consequently, Reagents & Consumables lead the market by product type, driven by recurring procurement cycles across academic, biopharma, and clinical research settings. Drug Discovery & Development anchors the application segment with , supported by the NMPA's record approval of 48 first-in-class innovative drugs in 2024 across nearly 20 therapeutic areas. As China's biopharmaceutical industry deepens its reliance on protein-level validation, the market is positioned for sustained double-digit growth through 2032, as stated in the recent report “China Proteomics Market Analysis, 2026”.

China Proteomics Market Highlights

The China Proteomics Market was valued at USD 3.88 billion in 2025 and is projected to reach USD 7.99 billion by 2032, expanding at a CAGR of 11.27% during 2026–2032.
The market is moderately fragmented, with the top 5 players collectively holding approximately 30% combined share, leaving significant room for emerging domestic and international competitors.
Reagents & Consumables dominate the market with approximately 55% share, driven by recurring procurement cycles across academic, biopharma, and clinical research settings throughout China.
Drug Discovery & Development leads the application segment with approximately 45% share, supported by China's NMPA record approval of 48 first-in-class innovative drugs in 2024 across 20 therapeutic areas.

China Proteomics Market Segmentation

By Technology Platform

Mass Spectrometry
- Electrospray Ionization MS (ESI-MS)
- Matrix-Assisted Laser Desorption/Ionization MS (MALDI-MS)
- Tandem Mass Spectrometry (MS/MS)
Liquid Chromatography
- Reverse-Phase HPLC (RP-HPLC)
- Affinity Chromatography
- Ion Exchange Chromatography (IEC)
- Supercritical Fluid Chromatography (SFC)
Electrophoresis
- Two-Dimensional Gel Electrophoresis (2D-PAGE)
- Capillary Electrophoresis (CE)
Protein Microarray
- Antibody Microarray
- Reverse-Phase Protein Array (RPPA)
- Functional Protein Array
Surface Plasmon Resonance (SPR)
Nuclear Magnetic Resonance (NMR) Spectroscopy
X-Ray Crystallography

By Product Type

Instruments & Equipment
- Mass Spectrometers
- Liquid Chromatography Systems
- Electrophoresis Systems
- Microarray Scanners & Arrayers
- SPR Instruments
- NMR Spectrometers
- X-Ray Crystallography Systems
- Others
Reagents & Consumables
- Sample Preparation Reagents
- Stable Isotope Labeling Reagents
- Immunoassay Reagents
- Chromatography Consumables
- Electrophoresis Reagents
- Microarray Reagents
- Crystallography Reagents
- Others
Software & Informatics Tools
- Proteome Data Analysis Software
- Quantification & Statistical Analysis Tools
- Pathway & Network Analysis Platforms
- Protein Structure Prediction Software
- Bioinformatics Databases & Repositories
Services
- Protein Identification & Characterization Services
- Quantitative Proteomics Services
- Structural Proteomics Services
- Protein Production & Purification Services
- Biomarker Discovery & Validation Services
- Custom Assay Development Services
- Bioinformatics & Data Analysis Services

By Application

Drug Discovery & Development
- Target Identification & Validation
- Lead Identification & Optimization
- Preclinical & Toxicological Studies
- Clinical Trial Proteomics
Clinical Diagnostics
- Oncology
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Diseases
- Metabolic & Endocrine Disorders
- Autoimmune Diseases
- Renal Diseases
- Others
Fundamental & Academic Research
- Basic Protein Biology
- Structural Biology
- Systems Biology & Multi-Omics
Agricultural & Food Science
- Crop & Plant Proteomics
- Food Quality & Safety Testing
- Animal Health & Veterinary Proteomics
Environmental Proteomics
- Environmental Monitoring & Microbial Ecology
- Ecotoxicology
- Others